The goals of this project are (1) to define the kinetics and estimate the numbers of hematopoietic stem cells in normal individuals and in individuals with sickle cell disease and (2) to develop a genetic therapy for sickle cell disease based on the induction of fetal hemoglobin in adults. Our preliminary studies, performed over a 912 day period of observation in healthy females, suggest that cloned succession of hematopoietic stem cells does not occur in healthy females, suggest that clonal succession of hematopoietic stem cells does not occur in healthy females. We propose to extend these studies over a longer time period, to repeat the analyzes in females with sickle cell disease, and to determine whether clonal succession occurs in these patients whose bone marrow is under significant stress. The data derived from these experiments will provide critical insights into stem cell biology in control and stress conditions and will provide information that is important for designing genetic therapies for sickle cell disease. The proposed studies of HbF synthesis are based in part on the investigation of an Alabama African- American family in which two homozygous siblings with beta thalassemia are non-anemic because of full substitution of adult HbA by HbF. Heterozygous relatives were microcytic , had elevated HbA/2 levels and expressed variable levels of HbF. No gamma-globin gene promoter or enhancer sequences previously associated with elevated HbF were found. The segregation of these chromosomes in heterozygous relatives revealed that the paternal beta thalassemic chromosome (Cameroon-like Benin-like hybrid) was associated with low HbF expression. We propose to determine the regulatory sequences responsible for high HbF (98%) in this family and to incorporate these sequences into AAV or retroviral vectors containing gamma-globin genes. Hematopoietic stem cells from sickle cell patients will be transduced with these viruses and high level expression of gamma polypeptides in adult cells will inhibit HbS polymerization and, consequently, inhibit erythrocyte sickling. In a second approach, the regulatory elements responsible for normal gamma-to beta-globin gene switching in humans will be defined in transgenic mouse assay. When proteins that bind to these sequences are defined, cDNA clones will be isolated and over-expressed in adult erythroid cells to reactivate gamma- globin gene expression.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL058418-02
Application #
6110846
Study Section
Project Start
1999-04-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Coats, Mamie T; Benjamin, W H; Hollingshead, S K et al. (2005) Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae. Vaccine 23:4257-62
Telfair, Joseph; Alexander, Leah R; Loosier, Penny S et al. (2004) Providers' perspectives and beliefs regarding transition to adult care for adolescents with sickle cell disease. J Health Care Poor Underserved 15:443-61
Briles, David E; Hollingshead, Susan K; Paton, James C et al. (2003) Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis 188:339-48
Liu, Enli; Jelinek, Jaroslav; Pastore, Yves D et al. (2003) Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood 101:3294-301
Aslan, Mutay; Ryan, Thomas M; Townes, Tim M et al. (2003) Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem 278:4194-204
Lim, Dong Gun; Sweeney, Scott; Bloodsworth, Allison et al. (2002) Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc Natl Acad Sci U S A 99:15941-6
Coles, Barbara; Bloodsworth, Allison; Eiserich, Jason P et al. (2002) Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J Biol Chem 277:5832-40
Coles, Barbara; Bloodsworth, Allison; Clark, Stephen R et al. (2002) Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res 91:375-81
Robinson, D Ashley; Briles, David E; Crain, Marilyn J et al. (2002) Evolution and virulence of serogroup 6 pneumococci on a global scale. J Bacteriol 184:6367-75
O'Donnell, V B; Freeman, B A (2001) Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res 88:12-21

Showing the most recent 10 out of 22 publications